The Carmel Redevelopment Commission on Wednesday approved spending $20,000 per month for hospitality industry advice that could help it bring an Autograph Collection hotel to the City Center project.
A homebuilder wants to tear down the vacant, century-old building and construct 34 townhomes on the site, which is in the middle of an area on the rise.
Marketing and development staffers are learning to be much more sophisticated and data-savvy in helping attorneys establish relationships with prospective clients.
An IPS committee recommended closing three of the seven high schools that will be in operation this fall. Some schools are clearly in more danger of closing than others.
A federal agency likely will step in and pick up the unfunded-pension tab once Marsh Supermarkets exits Chapter 11 bankruptcy. That's not an unusual situation for companies that have been owned by private equity firm Sun Capital Partners.
Dr. John Steenbergen admitted he had a sexual relationship with a patient for five years and performed an abortion on her, but said the licensing board unfairly characterized the matter.
Meanwhile, the Indiana Fever signs a deal with a local marketing firm to build on the team’s strong sales in 2016, and the Indianapolis Motor Speedway educates its fans on organ donation.
Health insurers are asking for sharp increases in the cost of their Obamacare plans next year. In the first states to make the latest rates public, premiums for Affordable Care Act plans will rise more than 20 percent on average.
Telecommunications company Sinclair Broadcast Group is buying rival Tribune Media Co. in a deal between the nation’s two largest TV station owners. Tribune Media owns two Indianapolis TV stations.
U.S. Sen. Joe Donnelly said in a statement that the VA and Crown Hill will pursue a land swap that would allow a national cemetery to be built on an adjacent parcel of land.
No one knows how the $505 million sale of Angie’s List Inc. to New York media and internet company IAC will affect local employment, but the buyer doesn’t seem interested in slash and burn.
Around Indiana, life sciences companies are searching high and low for venture capital to fund promising but expensive new products, which can take a decade or longer to develop.
